Is ECTE a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

448 people get ECTE articles and Market Currents by email alert.

Get email alerts on ECTE »

HEADLINES:

Echo Therapeutics Announces Institutional Review Board (IRB) Approval for Its Clinical Trial of the Symphony® CGM System

PR Newswire (Tue, 7:50AM)
Dario Seeks To Capitalize On New Technology For Diabetic Test Strips
Microcap Millionaires • Thu, May 16
Echo Therapeutics to Unveil Symphony® CGM System in Webcast

PR Newswire (Thu, 7:50AM)
LabStyle Innovations - Glucose Monitoring For The Mobile Age
Jason Napodano • Wed, May 15 • 12 Comments
Echo Therapeutics Announces First Quarter 2013 Financial Results

PR Newswire (May 10, 2013)
Echo Therapeutics, Inc. Announces 2012 Financial Results

PR Newswire (Mar 18, 2013)
Echo Therapeutics Achieves ISO 13485 Certification

PR Newswire (Mar 15, 2013)
Echo Therapeutics Appoints Robert Doman to Board of Directors

PR Newswire (Mar 13, 2013)
Echo Therapeutics Granted U.S. Patent for Prelude® SkinPrep System

PR Newswire (Mar 12, 2013)
Echo Therapeutics Announces Closing of Public Offering of Common Stock

PR Newswire (Feb 6, 2013)
Echo Therapeutics Announces Pricing of Public Offering of Common Stock

PR Newswire (Jan 31, 2013)
Echo Therapeutics Announces Proposed Public Offering

PR Newswire (Jan 31, 2013)
Echo Therapeutics Presents Positive Clinical Trial Results of the Symphony® tCGM System at the 42nd Critical Care Congress

PR Newswire (Jan 22, 2013)
Echo Therapeutics to Present at the Noble Financial Capital Markets' Ninth Annual Equity Conference

PR Newswire (Jan 15, 2013)
Echo Therapeutics, Inc. (Nasdaq: ECTE) Provides an Update to Shareholders

PR Newswire (Jan 7, 2013)
Echo Therapeutics Announces Closing of Public Offering of Common Stock

PR Newswire (Dec 27, 2012)
Echo Therapeutics to Present at Biotech Showcase 2013 in San Francisco

PR Newswire (Dec 27, 2012)
Echo Therapeutics Announces Full Exercise of Over-Allotment Option

PR Newswire (Dec 26, 2012)
Echo Therapeutics Announces Pricing of Public Offering of Common Stock

PR Newswire (Dec 20, 2012)
Echo Therapeutics Announces Proposed Public Offering

PR Newswire (Dec 20, 2012)

To learn more about Seeking Alpha Pro, click here.

Echo Therapeutics: Speculative Stock With Significant Upside Potential
David Zanoni • Mon, Dec 3, 2012 • 7 Comments
4 Reasons To Buy Echo Therapeutics
Markus Aarnio • Tue, May 29, 2012 • 8 Comments
Good News For Echo Therapeutics' Glucose Monitoring System
M. E. Garza • Thu, Oct 6, 2011
Echo Therapeutics: The Next 10-Bagger
David Zanoni • Tue, Aug 16, 2011 • 11 Comments
Echo Therapeutics: Positive Developments for a Needle-Free Diabetes Monitoring System
Mike Havrilla • Thu, Nov 19, 2009 • 4 Comments

Dario Seeks To Capitalize On New Technology For Diabetic Test Strips
Microcap Millionaires • Thu, May 16
LabStyle Innovations - Glucose Monitoring For The Mobile Age
Jason Napodano • Wed, May 15 • 12 Comments
5 Healthcare Companies With Insider Buying Filed On August 22 - 23
Markus Aarnio • Sat, Aug 25, 2012 • 2 Comments
6 Low Debt Pharmaceutical Stocks Rated Buy Or Better
ZetaKap • Mon, May 14, 2012 • 2 Comments
Cashing In On Diabetes: Novel Approaches
Jessica King Holden • Wed, Mar 7, 2012 • 3 Comments
Biotechnology FDA Approval Catalyst Strategy
David Pope - S&P Capital IQ • Fri, Jan 13, 2012 • 7 Comments
20 Micro-Cap Stocks Being Snapped Up By Hedge Funds
Kapitall • Thu, Dec 15, 2011
20 Healthcare Stocks Deeply Undervalued By Target Price
Kapitall • Wed, Nov 23, 2011 • 2 Comments
17 High-Growth Healthcare Stocks Being Bought Up By Hedge Funds
Kapitall • Sun, Nov 20, 2011 • 2 Comments
5 OTCBB Stocks That Began Trading on Major Exchanges in June
Alex Shadunsky • Tue, Jul 12, 2011 • 1 Comment
Diabetes Care: Global Investing Opportunities
Mike Havrilla • Sun, Nov 22, 2009 • 4 Comments

Echo Therapeutics's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Fri, Nov 9, 2012

Echo Therapeutics Announces Institutional Review Board (IRB) Approval for Its Clinical Trial of the Symphony® CGM System

PR Newswire (Tue, 7:50AM)
Echo Therapeutics to Unveil Symphony® CGM System in Webcast

PR Newswire (Thu, 7:50AM)
Echo Therapeutics Announces First Quarter 2013 Financial Results

PR Newswire (May 10, 2013)
Echo Therapeutics, Inc. Announces 2012 Financial Results

PR Newswire (Mar 18, 2013)
Echo Therapeutics Achieves ISO 13485 Certification

PR Newswire (Mar 15, 2013)
Echo Therapeutics Appoints Robert Doman to Board of Directors

PR Newswire (Mar 13, 2013)
Echo Therapeutics Granted U.S. Patent for Prelude® SkinPrep System

PR Newswire (Mar 12, 2013)
Echo Therapeutics Announces Closing of Public Offering of Common Stock

PR Newswire (Feb 6, 2013)
Movers & Shakers: Friday’s biggest gaining and declining stocks

at MarketWatch.com (Feb 1, 2013)
Echo Therapeutics Announces Pricing of Public Offering of Common Stock

PR Newswire (Jan 31, 2013)
Echo Therapeutics Announces Proposed Public Offering

PR Newswire (Jan 31, 2013)
Echo Therapeutics Presents Positive Clinical Trial Results of the Symphony® tCGM System at the 42nd Critical Care Congress

PR Newswire (Jan 22, 2013)
Echo Therapeutics to Present at the Noble Financial Capital Markets' Ninth Annual Equity Conference

PR Newswire (Jan 15, 2013)
Echo Therapeutics, Inc. (Nasdaq: ECTE) Provides an Update to Shareholders

PR Newswire (Jan 7, 2013)
Echo Therapeutics Announces Closing of Public Offering of Common Stock

PR Newswire (Dec 27, 2012)
Echo Therapeutics to Present at Biotech Showcase 2013 in San Francisco

PR Newswire (Dec 27, 2012)
Echo Therapeutics Announces Full Exercise of Over-Allotment Option

PR Newswire (Dec 26, 2012)
Echo Therapeutics Announces Pricing of Public Offering of Common Stock

PR Newswire (Dec 20, 2012)
Echo Therapeutics Announces Proposed Public Offering

PR Newswire (Dec 20, 2012)
Echo Therapeutics to Present Clinical Study Results of Symphony® tCGM System at the 42nd Critical Care Congress

PR Newswire (Dec 12, 2012)

ECTE vs. ETF Alternatives

Company Description

Currently, there's no company description for ECTE.

Sector: Healthcare

Industry: Medical Appliances & Equipment

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Tuesday, May 21, 10:27 AM Echo Therapeutics (ECTE +2%) settles in following in 12% jump after the opening bell on the company's announcement that the clinical trial of its Symphony CGM System has received Institutional Review Board approval. The board approval enables the Symphony system, which is a non-invasive, wireless, transdermal continuous glucose monitoring platform, to offically start clinical evaluations for a European CE Mark. Comment! [Healthcare]
Friday, May 10, 7:55 AM Echo Therapeutics (ECTE): Q1 EPS of -$0.13 misses by $0.03. Revenue of $22.56M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Tuesday, March 12, 11:03 AM Echo Therapeutics (ECTE +6.7%) says it's been granted a patent for its Prelude SkinPrep System, a device and method for preparing the skin to allow for analyte extraction or drug delivery. The system is a component of the company's Symphony GSM System, a non-invasive glucose monitoring system. Comment! [Healthcare, On the Move]
Friday, February 1, 4:02 PM Echo Therapeutics (ECTE -29.4%) gets slammed today, after it prices its previously announced 13.3M share offering at $0.75 apiece, a 35% discount to Thursday's closing price. 1 Comment [Healthcare, On the Move]
Friday, February 1, 12:45 PM Midday top 10 gainers: OTT +31%. ALIM +25%. BBW +22%. ADNC +21%. PSDV +16%. EDAP +16%. ABAX +15%. CRR +14%. CIS +11%. PMCS +12%.
Midday top 10 Losers: ECTE -31%. EBOD -28%. BCOV -23%. CKH -22%. LTM -20%. KERX -17%. CLSN -14%. SDR -14%. CBMX -11%. PXLW -11%. Comment! [On the Move]
Friday, February 1, 9:10 AM Premarket gainers: ADNC +30%. TSYS +15%. RAD +9%. CTRP +8%. EDAP +7%. ALU +6%. DELL +6%. VVUS +5%. PRGO +5%.
Losers: ECTE -35%. OTT -23%. LTM -16%. SDR -11%. OCZ -8%. CLSN -7%. ALKS -7%. NMM -6%. TLAB -5%. Comment! [On the Move]
Thursday, January 31, 6:48 PM Echo Therapeutics (ECTE) announces a secondary offering, but no details of the size or terms were given. Aegis Capital is acting as the sole book-running manager for the offering. Shares -7.8% AH. Comment! [Healthcare, On the Move]
Friday, January 25, 9:10 AM Premarket gainers: INFA +10%. TPX +10%. ECTE +9%. OSK +8%. STP +6%. THLD +7%. SNE +6%.
Losers: SCSS -15%. BGMD -15%. EGHT -10%. SFL -8%.
1 Comment [On the Move]
Tuesday, January 22, 2:04 PM Echo Therapeutics (ECTE -6%) slips despite presenting positive results from an expanded analysis of data collected from clinical studies of its Symphony tCGM glucose monitoring system in critically ill patients at Tufts Medical Center in Boston. The data was presented during over the weekend at the Society of Critical Care Medicine's 42nd Critical Care Congress. Comment! [Healthcare, On the Move]
Friday, December 21, 2012, 12:45 PM Midday top 10 gainers: HALO +27%. CEMI +24%. ASCA +20%. FCFC +18%. PNK +17%. ABCD +14%. ATAI +12%. BONA +11%. WWAY +9%. IKAN +9%.
Midday top 10 Losers: CT -52%. ALX -26%. RIMM -21%. EDMC -19%. MSON -17%. ECTE -17%. HLF -14%. OPXA -13%. MHH -12%. AMPL -11%. 3 Comments [On the Move]
Friday, December 21, 2012, 12:43 PM Echo Therapeutics (ECTE -17%) trades lower today after the company priced its previously announced 3.2M secondary offering at $0.95 per share, an 18% discount to yesterday's close. Aegis Capital is the sole book-running manager for the offering. Comment! [Healthcare, On the Move]
Friday, December 21, 2012, 9:10 AM Premarket gainers: HALO +19%. CEMI +17%. ASCA +17%. APPY +14%. RHT +5%. PNK +5%. SHP +5%.
Losers: ECTE -18%. RIMM -14%. ALU -7%. 1 Comment [On the Move]
Wednesday, October 10, 2012, 12:45 PM Midday top 10 gainers: CLNT +28%. TRLG +23%. AUQ +17%. KGN +15%. PBM +14%. OTT +12%. BLIN +19%. KID +12%. VVTV +12%. ECTE +9%.
Top 10 Losers: OCZ -40%. ACW -32%. FOE -24%. GLUU -14%. BSET -11%. HELE -10%. BSDM -10%. UPI -10%. AMRN -10%. TZYM -9%. Comment! [On the Move]
Thursday, June 14, 2012, 7:03 AM Russell Investments is reshuffling the Russell Microcap Index (IWC) on June 25. New additions to the index include CytRx (CYTR), Synergy Resources (SYRG) and Echo Therapeutics (ECTE). The full list of changes (here) will be finalized June 22. Comment!

pedromm
ECTE Rebounding
5/22/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
$$ 6 Low Debt Pharmaceutical Stocks Rated Buy Or Better http://bit.ly/L0WSca $ASTX $ECTE $IPXL $KERX $RIGL $VTUS @ZetaKap #pharma
5/14/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
$$ Just posted: 6 Low Debt Pharmaceutical Stocks Rated Buy Or Better http://bit.ly/L0WSca $ASTX $ECTE $IPXL $KERX $RIGL $VTUS @ZetaKap
5/14/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

The Illogical Investor
Echo Therapeutics ticker ECTE. Announces positive results from trial of non invasive glucose monitoring system and direct capital raise
12/6/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

David Zanoni
ECTE is trading in a channel approx. between $3 & $4 - it is now at the low end of the channel at $2.92
10/23/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Nadia Kageff
Advice to ECTE - SOUNDS GOOD, HOPE TO BUY SHARES. IPO,WHEN? NKAGEFF1@HOTMAIL.COM
11/19/09
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

ECTE Echo Therapeutics

ECTE

Echo Therapeutics